Joyance 2

Joyance 2 is an early-stage venture capital fund established in 2022 and managed by Joyance Partners, a firm founded in 2012 and based in San Francisco, California. With a focus on investing in startups and emerging companies, Joyance 2 aims to support innovations in the healthcare sector that enhance individual well-being and promote personal empowerment. The fund operates across the United States, Canada, and Europe, seeking to back ventures that can create meaningful and positive experiences for consumers. Joyance Partners emphasizes investments that contribute to improved health outcomes and increased joy and fulfillment in everyday life.

Omar Al-Busaidi

Investment Partner and Venture Partner

Yang Chen

Investor

Sonia Dewar

Investment Partner

Mike Edelhart

Managing Partner

Toshi Eguchi

Partner

Emi Gonzalez

Venture Partner

Jun Li

Venture Partner

William Lohse

Founder Joyance Europe

Hidenari Nakayama Ph.D

Venture Partner, Joyance Partners

Neal O'Hara

Venture Partner

Seth Rosenblatt

Venture Partner

Charles Smith

Venture Partner

Nobuhiro Takanuma

Partner, Joyance Partners

Neha Tanna

Venture Partner

Shu Tsukui Ph.D

Venture Partner, Joyance Partners

Past deals in Wearables

Epicore Biosystems

Series A in 2022
Epicore Biosystems, Inc. has developed a proprietary wearable microfluidic platform that is ‘skin-like’ and capable of analyzing small droplets of sweat for proteomics, inflammatory markers, hydration, and health biomarkers to enable personalized management of health, performance and nutrition. Epicore's wearable sensing technology is based on over two decades of microfluidics and soft materials research by Prof. John Rogers and Prof. Roozbeh Ghaffari at Northwestern University's Querrey-Simpson Institute for Biolectronics.

Aether Biomedical

Seed Round in 2021
Aether Biomedical Sp. z o.o operates as a medical robotics company focused on bio signal processing and bionic limbs for upper limb amputees. It offers a product Zeus, a multi-action bionic limb combining ease of control and can be used without any additional coverage or with a silicone glove. The company was founded in 2016 and is based in Poznan, Poland.

Sharper Sense

Seed Round in 2021
Sharper Sense is a developer of wearable neuromodulation device. The noninvasive bioelectronic device is used to improve sensory loss and perceptual acuity by optimizing the brain's ability to process sensory information.

Zone7

Series A in 2021
The future of human performance starts now. Zone7 is used by more than 30 professional sports franchises to track performance and injury risk of some of the world’s leading athletes. Zone7 is also being used to monitor the physical wellbeing of medical staffs in leading hospitals around the world. By analyzing data from wearables, video cameras, medical records and various biomechanics metrics, Zone7 provides coaching staffs and hospital administrators with actionable advice to positively influence rest, work assignment, and planning to protect and optimize human performance.

Zone7

Series A in 2021
The future of human performance starts now. Zone7 is used by more than 30 professional sports franchises to track performance and injury risk of some of the world’s leading athletes. Zone7 is also being used to monitor the physical wellbeing of medical staffs in leading hospitals around the world. By analyzing data from wearables, video cameras, medical records and various biomechanics metrics, Zone7 provides coaching staffs and hospital administrators with actionable advice to positively influence rest, work assignment, and planning to protect and optimize human performance.

Expectful

Seed Round in 2021
Expectful is a digital subscription platform that makes it easy for expectant and new moms to meditate.

Attn: Grace

Pre Seed Round in 2020
Attn: Grace, Inc. is a Boston-based company that specializes in manufacturing and selling wellness products focused on women's hygiene, particularly for those experiencing urinary incontinence. Established in 2017, the company offers a range of products including pads, briefs, liners, and wipes, all designed with sustainability in mind. Attn: Grace aims to provide discreet and elegantly packaged solutions that utilize natural fibers derived from sugarcane waste, catering to the needs of women as they age. The company sells its products online, addressing life’s inconvenient challenges with thoughtful and environmentally conscious offerings.

Zone7

Venture Round in 2020
The future of human performance starts now. Zone7 is used by more than 30 professional sports franchises to track performance and injury risk of some of the world’s leading athletes. Zone7 is also being used to monitor the physical wellbeing of medical staffs in leading hospitals around the world. By analyzing data from wearables, video cameras, medical records and various biomechanics metrics, Zone7 provides coaching staffs and hospital administrators with actionable advice to positively influence rest, work assignment, and planning to protect and optimize human performance.

Oga

Seed Round in 2020
Oga is developing an interactive fitness platform that aims to create a fully immersive workout experience. Utilizing advanced technology, Oga tracks and analyzes the movements of users through any device's camera, providing real-time feedback that simulates the experience of a personal workout studio. The platform allows individuals to participate in live sessions with trainers, enhancing the motivation and engagement typically found in in-person classes. By monitoring 18 joints of the human body, Oga's motion comparison technology ensures that users receive accurate guidance on their movements, enabling them to exercise effectively anytime and anywhere.

Aether Biomedical

Seed Round in 2020
Aether Biomedical Sp. z o.o operates as a medical robotics company focused on bio signal processing and bionic limbs for upper limb amputees. It offers a product Zeus, a multi-action bionic limb combining ease of control and can be used without any additional coverage or with a silicone glove. The company was founded in 2016 and is based in Poznan, Poland.

IDUN Technologies

Convertible Note in 2020
IDUN Technologies AG is a Swiss neurotechnology startup founded in 2017, specializing in the design and manufacture of advanced biosensors for wearable devices. The company is known for its innovative product, DRYODES, which features dry conductive electrodes suitable for electrocardiography (ECG), electroencephalography (EEG), and electromyography (EMG) applications. These electrodes enhance user convenience by providing soft, skin-conformable surfaces that eliminate the need for adhesives. IDUN Technologies aims to integrate neuroscience into everyday products through its Guardian Neuro-Intelligence Platform, a Brain-Computer Interface that captures real-time neuro markers. This platform enables the collection and analysis of brain activity data, allowing manufacturers to enhance their products by tailoring them to users' emotional and cognitive states. By employing a holistic approach that encompasses biosensor development, hardware design, data analysis, and product integration, IDUN Technologies seeks to create a more connected world where devices can respond to human emotional needs, ultimately fostering more fulfilling user experiences.

Feebris

Funding Round in 2020
Feebris Ltd is a technology company founded in 2017 and based in Saffron Walden, United Kingdom. The company specializes in developing artificial intelligence and machine learning algorithms aimed at the detection of respiratory conditions. Its platform integrates with various point-of-care devices, such as digital stethoscopes and wearables, to facilitate community-based diagnosis and monitoring. By leveraging its AI-driven software, Feebris enables non-clinical users to identify clinical deterioration early, thereby helping to prevent complications and reduce hospitalizations. The team at Feebris combines expertise in biomedical engineering, machine learning, and global health, all driven by a commitment to transforming healthcare into a more equitable, personalized, and patient-centered system.

CognifiSense

Funding Round in 2020
CognifiSense, Inc. is a company based in Sunnyvale, California, that specializes in developing virtual reality (VR) software for pain management and mental health conditions. Founded in 2015, CognifiSense focuses on creating innovative digital therapeutics, particularly through its virtual reality neuropsychological therapy (VRNT) solution. This technology is designed to help chronic pain patients by normalizing their pain perception through psychological and experiential training. Additionally, the company offers pain measurement software that complements its therapeutic offerings. By combining neuroscience with proprietary technology, CognifiSense aims to address maladaptive neuroplastic changes in the brain, facilitating corrective neuroplastic changes that enhance both mental and physical health for its users.

Noctrix Health

Funding Round in 2020
Noctrix Health, Inc. is an early-stage medical device company based in Menlo Park, California, founded in 2018. The company specializes in the development of therapeutic wearable devices aimed at treating chronic neurological and sleep disorders. By focusing on innovative therapies, Noctrix Health seeks to address the unmet needs of patients suffering from these conditions.

FIGUR8

Funding Round in 2020
FIGUR8, Inc. is a Boston-based company established in 2016 that specializes in manufacturing wearable sensors designed to measure body movement as a biomarker for musculoskeletal-related conditions. The company also offers a platform that tracks and analyzes musculoskeletal health data, aiming to provide insights into human movement. Founded by a team of engineers, researchers, and designers with backgrounds in wearable computing, digital health, and sports science, FIGUR8 focuses on making advanced movement analysis accessible to a broader audience, moving beyond the elite users to everyday individuals.

Folia Health

Convertible Note in 2020
Folia Health, Inc. is a company based in Cambridge, Massachusetts, founded in 2016, that has developed a web application aimed at improving patient care through the insights of family caregivers. This application allows caregivers to capture and store daily observations related to a patient's health, including treatment usage, symptoms, and behavioral changes. By facilitating the entry and tracking of subtle health indicators—such as mood shifts, side effects, and treatment effectiveness—Folia Health provides essential data to the care team during medical appointments. This patient management tool is particularly beneficial for managing chronic conditions, enabling caregivers to monitor and communicate critical health information. Ultimately, Folia Health contributes to a more patient-centered healthcare approach, enhancing diagnostic precision and improving overall care outcomes through the aggregation of longitudinal health data.

Breakthrough

Convertible Note in 2020
Breakthrough build privacy-focused applications that support people living with chronic disease and connect them to researchers.

AVA

Venture Round in 2019
AVA is a developer of a lightweight health device that monitors and filters pollutants. Its health device uses air quality sensors to filter small particles, which can be charged using a USB port and regulated through an application with the increasing levels of air impurities that enable users to protect themselves from specific pollutant details that can negatively affect their health.

H2L

Venture Round in 2019
H2L Inc. researches, develops, sells, and licenses electric stimulation devices to aid the controlling of finger movement. It offers UnlimitedHand, a VR gaming controller that reads hand’s gesture, and controls fingers and hand by EMS(electronic muscle stimulation); and enables users to touch and feel a pseudo-object in the virtual world. The company also offers PossessedHand, a device with a forearm belt to control human fingers by applying electrical stimulus to the muscles around the forearm. Its PossessedHand is used in rehabilitation and learning support applications. The company was founded in 2012 and is based in Tokyo, Japan.

Embr Labs

Series B in 2019
Embr Labs Inc. is a technology company based in Somerville, Massachusetts, that specializes in thermal comfort solutions. Founded by three MIT scientists in 2014, the company develops wearable devices designed to help individuals control their body temperature. Its flagship product, the Embr Wave, is an intelligent bracelet that employs advanced algorithms to create temperature sensations in waves, effectively engaging the body's natural response to temperature changes. By utilizing patented technology, Embr Labs aims to provide a safe and non-invasive means for users to experience improved comfort, whether at home or on the go. The company has garnered support from notable investors, including Bose Ventures and Intel Capital, reflecting its innovative approach to wellness through technology.

Limbic

Convertible Note in 2019
Limbic is a London-based company founded in 2017 that specializes in developing a software development kit (SDK) aimed at enhancing emotional intelligence in applications. The SDK allows developers to integrate features that measure users' heartbeats through wearable devices, such as the Apple Watch, and utilize machine learning to analyze emotional states. This technology supports the creation of applications that can detect stress and facilitate more natural interactions, akin to human communication. By leveraging neuroscience and artificial intelligence, Limbic aims to provide scalable solutions to address the growing mental health challenges, ultimately assisting professionals in improving the mental well-being of their patients.

FIGUR8

Seed Round in 2019
FIGUR8, Inc. is a Boston-based company established in 2016 that specializes in manufacturing wearable sensors designed to measure body movement as a biomarker for musculoskeletal-related conditions. The company also offers a platform that tracks and analyzes musculoskeletal health data, aiming to provide insights into human movement. Founded by a team of engineers, researchers, and designers with backgrounds in wearable computing, digital health, and sports science, FIGUR8 focuses on making advanced movement analysis accessible to a broader audience, moving beyond the elite users to everyday individuals.

Wynd

Seed Round in 2019
Wynd Technologies, Inc. specializes in manufacturing portable air purifiers designed for personal use. The company's flagship product, the Wynd air purifier, features a removable sensor that assesses air quality and activates purification as needed, effectively removing allergens and pollutants. In addition to the standard model, Wynd offers the Wynd Halo pro, which provides real-time air quality measurement and monitoring to ensure optimal performance and maintenance. Wynd Technologies, originally established as Claireau, Inc. in 2014, is headquartered in San Jose, California. The company also engages in online retail, providing convenient access to its products. With a commitment to creating healthier environments, Wynd Technologies aims to enhance indoor air quality for both residential and commercial spaces.

Paradromics

Seed Round in 2019
Paradromics, Inc. is focused on developing brain-machine interfaces that facilitate data transmission between the brain and machines, primarily targeting the treatment of neurodegenerative diseases. The company creates implantable systems capable of decoding complex neural recordings into data streams, which can be utilized by various neural prostheses. Its technology emphasizes high-volume, bidirectional data streaming, allowing patients with neurological disorders to reconnect with their environment and compensate for lost biological connectivity. Founded in 2015 and headquartered in Austin, Texas, Paradromics also offers applications to support its product suite, aiming to enhance the quality of life for individuals with disabilities.

IrisVision

Seed Round in 2019
IrisVision is a leader in digital vision technologies, specializing in assistive devices for individuals with low vision. The company has developed a groundbreaking visual assistive device that utilizes wearable virtual reality technology. This innovative headset features a 12-megapixel camera and a 70-degree field of view on an LED display, allowing users to customize their experience according to their specific needs. The device aims to help vision-impaired individuals, including those with macular degeneration, regain clarity in their sight, promote independence, and enhance their quality of life.

Pnoe

Seed Round in 2019
PNOE focuses on democratizing cardio-metabolic analysis, providing comprehensive health assessments through its innovative device that delivers clinically accurate measurements of metabolic, cardiac, and pulmonary health. In just ten minutes, this analysis reveals critical insights necessary for creating tailored nutrition and workout plans. PNOE's technology is the first of its kind to be scientifically validated for mass market use, positioning it as a leader in the field of metabolic testing. The company is supported by experts in metabolic analysis and cardiovascular health, and its dedicated engineering team is committed to making cardio-metabolic analysis accessible to a broader audience.

NeoSensory

Series A in 2019
Neosensory, Inc. is a company that specializes in developing wearable devices aimed at enhancing sensory perception for individuals. Founded in 2015 and based in San Mateo, California, Neosensory offers products such as Buzz, which utilizes vision-to-touch sensory substitution technology to assist blind individuals. The company focuses on transmitting various data streams to the brain through the sense of touch, leveraging the skin's potential for information delivery. Their innovative approach includes building hearing assistive technology that allows users to perceive sound through vibrations on the skin. Neosensory also provides a companion application for its products, enhancing the user experience and accessibility of information.

Neurosity

Seed Round in 2018
Neurosity Inc., founded in 2018 and based in New York, specializes in thought-powered wearable devices designed to enhance communication and understanding of thoughts, feelings, and movements. The company's flagship product, the Notion, combines hardware and software to analyze brain wave data, helping users, particularly programmers, to improve their focus and concentration. By facilitating quicker and more sustained attention, Neurosity aims to boost productivity for its users.

Embr Labs

Series A in 2018
Embr Labs Inc. is a technology company based in Somerville, Massachusetts, that specializes in thermal comfort solutions. Founded by three MIT scientists in 2014, the company develops wearable devices designed to help individuals control their body temperature. Its flagship product, the Embr Wave, is an intelligent bracelet that employs advanced algorithms to create temperature sensations in waves, effectively engaging the body's natural response to temperature changes. By utilizing patented technology, Embr Labs aims to provide a safe and non-invasive means for users to experience improved comfort, whether at home or on the go. The company has garnered support from notable investors, including Bose Ventures and Intel Capital, reflecting its innovative approach to wellness through technology.

Wynd

Seed Round in 2018
Wynd Technologies, Inc. specializes in manufacturing portable air purifiers designed for personal use. The company's flagship product, the Wynd air purifier, features a removable sensor that assesses air quality and activates purification as needed, effectively removing allergens and pollutants. In addition to the standard model, Wynd offers the Wynd Halo pro, which provides real-time air quality measurement and monitoring to ensure optimal performance and maintenance. Wynd Technologies, originally established as Claireau, Inc. in 2014, is headquartered in San Jose, California. The company also engages in online retail, providing convenient access to its products. With a commitment to creating healthier environments, Wynd Technologies aims to enhance indoor air quality for both residential and commercial spaces.

Epicore Biosystems

Seed Round in 2018
Epicore Biosystems, Inc. has developed a proprietary wearable microfluidic platform that is ‘skin-like’ and capable of analyzing small droplets of sweat for proteomics, inflammatory markers, hydration, and health biomarkers to enable personalized management of health, performance and nutrition. Epicore's wearable sensing technology is based on over two decades of microfluidics and soft materials research by Prof. John Rogers and Prof. Roozbeh Ghaffari at Northwestern University's Querrey-Simpson Institute for Biolectronics.

Noctrix Health

Pre Seed Round in 2018
Noctrix Health, Inc. is an early-stage medical device company based in Menlo Park, California, founded in 2018. The company specializes in the development of therapeutic wearable devices aimed at treating chronic neurological and sleep disorders. By focusing on innovative therapies, Noctrix Health seeks to address the unmet needs of patients suffering from these conditions.

Hexis

Pre Seed Round in 2018
Hexis Inc. is a technology company based in Austin, Texas, founded in 2017, specializing in emotion recognition software. The company develops a modular emotion artificial intelligence that utilizes electroencephalography (EEG) factors, biometric data, and machine learning to detect human emotions in real-time. This technology is designed to enhance product customization and allows businesses to provide continuous and accurate personalization for mobile users. Hexis's software can be integrated with various sensors, making it compatible with smartphones, consumer applications, enterprise tools, and Internet of Things (IoT) devices, ultimately enabling brands to tailor user experiences based on the individual's current emotional state.

Lark

Series B in 2018
Lark Technologies, Inc. is a developer of a chronic disease prevention and management platform headquartered in Mountain View, California. Founded in 2010, the company provides the Lark application, which utilizes artificial intelligence alongside human coaching to deliver personalized, real-time support for individuals managing chronic conditions such as diabetes, prediabetes, and hypertension. The platform also integrates data on user activity, sleep, and nutrition to enhance health outcomes. Lark's programs, including its CDC-recognized Diabetes Prevention Program and Hypertension Program, have garnered around 1.5 million users and are backed by clinical evidence published in peer-reviewed journals. The company serves employers and health plans, aiming to deliver compassionate care at scale.

Flux Bioscience

Seed Round in 2018
Flux Bioscience is a company that originated from Stanford University, focusing on developing a portable biosensor platform that allows for sensitive and quantitative point-of-care in vitro medical diagnostics. By repurposing technology initially designed for computer hard drives, Flux Bioscience's platform measures biomarkers in blood, urine, or saliva related to exercise, stress, fertility, and diet. The biosensor employs biochips equipped with sensors to detect specific biomarkers, facilitating the simultaneous measurement of multiple biomarkers within each sample. This technology enables real-time detection of magnetic nanoparticles through antibody-antigen interactions, providing users with accessible, affordable, and actionable health insights. By correlating these biomarker measurements with data from wearable technologies related to sleep and activity, Flux Bioscience empowers individuals to take control of their healthcare and lifestyle decisions.

NeoSensory

Convertible Note in 2018
Neosensory, Inc. is a company that specializes in developing wearable devices aimed at enhancing sensory perception for individuals. Founded in 2015 and based in San Mateo, California, Neosensory offers products such as Buzz, which utilizes vision-to-touch sensory substitution technology to assist blind individuals. The company focuses on transmitting various data streams to the brain through the sense of touch, leveraging the skin's potential for information delivery. Their innovative approach includes building hearing assistive technology that allows users to perceive sound through vibrations on the skin. Neosensory also provides a companion application for its products, enhancing the user experience and accessibility of information.

Hexis

Pre Seed Round in 2018
Hexis Inc. is a technology company based in Austin, Texas, founded in 2017, specializing in emotion recognition software. The company develops a modular emotion artificial intelligence that utilizes electroencephalography (EEG) factors, biometric data, and machine learning to detect human emotions in real-time. This technology is designed to enhance product customization and allows businesses to provide continuous and accurate personalization for mobile users. Hexis's software can be integrated with various sensors, making it compatible with smartphones, consumer applications, enterprise tools, and Internet of Things (IoT) devices, ultimately enabling brands to tailor user experiences based on the individual's current emotional state.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.